A new decade is here. And despite the incredible science, pharma is ill-equipped.
Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust
The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value
Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthc...